COVID-19 Resources > COVID-19 Web Series > Inflammatory Response

Presentation Slides

Wednesday, June 3
COVID-19 Inflammatory Response in Children & Adults

Dr. James Schneider will discuss the clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) and how cases have been diagnosed and treated.

Dr. Vincent Marconi will focus on the Hyperinflammatory Response associated with COVID-19 and the role of immunomodulators in treatment.



Multisystem Inflammatory Syndrome in Children (MIS-C)
James Schneider, MD, FAAP, FCCP, Chief, Pediatric Critical Care Medicine, Associate Professor of Pediatrics, Cohen Children’s Medical Center, New Hyde Park, NY

 _-2020_COVID_Webinar_Presenters/Marconi.jpg Immune Modulators for COVID-19
Vincent C. Marconi, MD, Professor, Division of Infectious Diseases, Emory University School of Medicine and Department of Global Health Rollins School of Public Health, Atlanta, GA

Series Partners

American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Academy of Emergency Nurse Practitioners (AAENP)American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | European Association of Poison Centers and Clinical
Toxicologists (EAPCCT)
 | Middle East & North Africa Clinical Toxicology Association (MENATOX)  

images/Web Series All LOGOS May 29.jpg